where do glp 1 drugs come from Glucagon-like peptide-1 receptor: mechanisms and advances in therapy The GLP-1 Access Gap: Mapping
Description
Using an anti-Dll4 monoclonal antibody in vivo , Fraser and colleagues showed that this resulted in increased luteal angiogenesis and microvascular density

GLP-1RAs can cause gastroparesis, requiring anaesthesia precautions due to aspiration risk

You can call it an incretin and satiety hormone

Alatassi adds, weight-loss drugs are no different than the medicines you might take to manage high blood pressure or diabetes

Healthcare providers should carefully evaluate the risk-benefit ratio in these situations, considering the metabolic benefits against theoretical concerns

Professional guidance is available through Healthcare.pro, where patients can connect with licensed healthcare professionals for individualized care
